Literature DB >> 12351166

Pleiotropic activity of hepatocyte growth factor during embryonic mouse testis development.

G Ricci1, A Catizone, M Galdieri.   

Abstract

The hepatocyte growth factor (HGF) is a pleiotropic cytokine whose action is mediated by c-met, a glycoproteic receptor with tyrosine kinase activity which transduces its multiple biological activities including cell proliferation, motility and differentiation. During embryonic development HGF acts as a morphogenetic factor as previously demonstrated for metanephric and lung development. Recently, culturing male genital ridges, we demonstrated that HGF is able to support in vitro testicular cord formation. In the present paper we report the expression pattern of the HGF gene during embryonic testis development and the multiple roles exerted by this factor during the morphogenesis of this organ. Northern blot analysis reveals a positive signal in urogenital ridges isolated from 11.5 days post coitum (dpc) embryos and in testes isolated from 13.5 and 15.5 dpc male embryos. On the contrary HGF mRNA is undetectable in ovaries isolated from 13.5 and 15.5 dpc embryos. Moreover, we demonstrate that HGF is synthesized and secreted by the male gonad and is biologically active. These data indicate a male specific biological function of HGF during embryonic gonadal development. This hypothesis is supported by the in vitro demonstration that HGF acts as a migratory factor for male mesonephric cells which is a male specific event. In addition we demonstrate that during testicular development, HGF acts as a morphogenetic factor able to reorganize dissociated testicular cells which, under HGF stimulation, form a tridimensional network of cord-like structures. Finally, we demonstrate that HGF induces testicular cell proliferation in this way being responsible for the size increase of the testis. All together the data presented in this paper demonstrate that HGF is expressed during the embryonic development of the testis and clarify the multiple roles exerted by this factor during the morphogenesis of the male gonad.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351166     DOI: 10.1016/s0925-4773(02)00247-2

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  7 in total

Review 1.  Development, function and fate of fetal Leydig cells.

Authors:  Qing Wen; C Yan Cheng; Yi-Xun Liu
Journal:  Semin Cell Dev Biol       Date:  2016-03-08       Impact factor: 7.727

2.  Autocrine expression of hepatocyte growth factor and its cytoprotective effect on hepatocyte poisoning.

Authors:  Yong He; Jun Zhou; Ke-Feng Dou; Yong Chen; Qing-Guo Yan; Hai-Min Li
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

3.  Microarray analysis of androgen-regulated gene expression in testis: the use of the androgen-binding protein (ABP)-transgenic mouse as a model.

Authors:  Peter Petrusz; Durairaj A Jeyaraj; Gail Grossman
Journal:  Reprod Biol Endocrinol       Date:  2005-12-09       Impact factor: 5.211

Review 4.  HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling.

Authors:  Chuan Xiang; Junxia Chen; Panfeng Fu
Journal:  Cancers (Basel)       Date:  2017-05-05       Impact factor: 6.639

5.  HGF Modulates Actin Cytoskeleton Remodeling and Contraction in Testicular Myoid Cells.

Authors:  Angela Catizone; Giulia Ricci; Maria Caruso; Michela Galdieri; Katia Corano Scheri; Virginia Di Paolo; Rita Canipari
Journal:  Biomedicines       Date:  2015-01-28

Review 6.  Pleiotropic Activities of HGF/c-Met System in Testicular Physiology: Paracrine and Endocrine Implications.

Authors:  Giulia Ricci; Angela Catizone
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-03       Impact factor: 5.555

7.  Analysis of Endocannabinoid System in Rat Testis During the First Spermatogenetic Wave.

Authors:  Marina Migliaccio; Giulia Ricci; Antonio Suglia; Francesco Manfrevola; Ken Mackie; Silvia Fasano; Riccardo Pierantoni; Teresa Chioccarelli; Gilda Cobellis
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.